Patents
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
08/2002
08/08/2002WO2002061052A2 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
08/08/2002US20020108151 Regulation of quinolate phosphoribosyl transferase expression
08/08/2002US20020106743 IL-17 homologous polypeptides and therapeutic uses thereof
08/08/2002US20020106728 NS4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
08/08/2002CA2434281A1 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
07/2002
07/31/2002CN1361823A Global regulators of bacterial pathogenic genes, bacterial autoinducer inactivation protein, as targets for engineering disease resistance
07/30/2002US6426071 Administering protein c
07/25/2002WO2002057425A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
07/25/2002WO2002057287A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
07/24/2002CN1360633A Fucosyl transferase gene
07/23/2002US6423520 Regulation of quinolate phosphoribosyl transferase expression
07/23/2002CA2072642C Fusion proteins consisting of a ligand binding protein and a stable plasma protein
07/18/2002WO2002055098A2 Latency associated peptide for providing latency to pharmaceutically active proteins
07/18/2002WO2002022776A3 Human coagulation factor vii variants
07/17/2002EP1222256A1 Method to improve the stability and broaden the ph range of family g/11 xylanases
07/16/2002CA2239360C G-csf analog compositions and methods
07/11/2002WO2002036737A3 Plant extract that inhibits release of tnf-alpha
07/11/2002WO2001094550A3 Identification and use of molecular markers indicating cellular reprogramming
07/11/2002US20020092037 Culturing plant cells on a support membrane; obtain solid support, incubate with plant cells, monitor plant cell propagation
07/04/2002WO2002051994A2 Polypeptides
07/04/2002WO2002026930A9 Nucleic acids, proteins, and antibodies
07/04/2002WO2001059063A3 Nucleic acids, proteins, and antibodies
07/04/2002US20020086368 Human toll homologues
07/04/2002US20020086356 Preferential nucleotide sequences for controlling preferential ribonucleic acids; for use in therapeutic genomics; for gene therapy
07/04/2002CA2782510A1 Polypeptides
07/02/2002US6413755 Human checkpoint kinase, HCDS1, compositions and methods
06/2002
06/18/2002CA2090122C Recombinant yeasts containing the dna sequences coding for xylose reductase-and xylitol dehydrogenase enzymes
06/13/2002WO2002046237A2 Humanized antibodies that recognize beta amyloid peptide
06/13/2002WO2001040798A3 Methods of using randomized libraries of zinc finger proteins for the identification of gene function
06/13/2002WO2000077262A9 Synthetic ligation reassembly in directed evolution
06/12/2002EP1212420A1 Conditional immortalisation of cells
06/06/2002WO2002044321A2 Rna interference mediating small rna molecules
06/06/2002WO2000024782A3 Modified peptides, comprising an fc domain, as therapeutic agents
06/06/2002CA2791831A1 Rna interference mediating small rna molecules
06/06/2002CA2429814A1 Rna interference mediating small rna molecules
06/04/2002US6399384 Conditional immortalization of cells
06/04/2002US6399374 A rodent-human cell line which maintains its human chromosomal content after 90 generations
05/2002
05/30/2002WO2002042429A2 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants
05/30/2002CA2427661A1 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants
05/29/2002EP1208197A1 Iren protein, its preparation and use
05/29/2002CN1351715A Use of genes of the deoxy-D-xylulose phosphate biosynthetic pathway for altering the concentration of isoprenoid
05/28/2002US6395961 Gene transfer in chickens by introduction of DNA into muscle in ovo
05/28/2002US6395548 Methods of modulating of angiogenesis
05/28/2002US6395519 Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer
05/28/2002CA1341362C Human manganese superoxide dismutase cdna, its expression in bacteria and method of recovering enzymatically active human manganese superoxide dismutase
05/23/2002WO2001085911A3 Chromosome 17p-linked prostate cancer susceptibility gene and a paralog and orthologous genes
05/23/2002WO2001083691A3 System for identifying and analyzing expression of are-containing genes
05/16/2002WO2001085913A3 High purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa
05/16/2002US20020058617 Effective for reducing body mass and for treating obesity-related diseases and disorderssuch as hyperlipidemias, atherosclerosis, diabetes, and hypertension.
05/16/2002US20020058290 Stable genetically engineered muscle cell; for use in the generation of modulators for treatment of cancer, metabolic defects, cachexia and aging defects
05/16/2002US20020058024 Modulators of the function of receptors of the TNF/NGF receptor family and other proteins
05/15/2002EP1205489A1 Polypeptide and nucleic acids encoding the same
05/14/2002US6387657 Amino acid sequence of wnt-1-induced secreted protein; anticarcinogenic agents; antitumor agents; treatment of arteriosclerosis; diagnosis of related disorders
05/14/2002US6387258 Method of purifying statins from a fermentation broth
05/10/2002WO2002036737A2 Plant extract that inhibits release of tnf-alpha
05/10/2002WO2001090304A3 Nucleic acids, proteins, and antibodies
05/10/2002WO2001066573A3 Corynebacterium glutamicum genes encoding metabolic pathway proteins
05/08/2002EP1203075A1 Cell culture systems and methods for organ assist devices
05/08/2002CN1348490A Method for the purification, recovery, and sporulation of cysts and oocysts
05/07/2002CA2223700C In ovo vaccination against coccidiosis
05/02/2002WO2002006460A3 Masp-2, a complement-fixing enzyme, and uses for it
05/02/2002WO2001081582A3 Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same
05/02/2002US20020052027 IL-17 homologous polypeptides and therapeutic uses thereof
05/02/2002EP1200606A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
05/02/2002EP1200605A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
05/02/2002CA2426896A1 Compositions and methods for the discovery and selection of biological information
04/2002
04/30/2002CA2020247C Antibodies reactive with human carcinomas
04/24/2002CN1346371A Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
04/18/2002WO2002030986A2 HUMANIZED ANTI-LT-β-R ANTIBODIES
04/18/2002US20020045591 For gene therapy including polynucleotide sequences encoding peptides including beta-catenin binding domains such as cadherins, for treating cancers with abnormally high levels of beta-catenin
04/18/2002US20020045251 Generating mammalian nervous system stem cells; obtain nervous system tissue, incubate with mitogen, monitor cells for differentiation into preferential tissues of nervous system
04/18/2002CA2811096A1 Enhanced selection of genetically modified pine embryogenic tissue
04/18/2002CA2425809A1 Humanized anti-lt-.beta.-r antibodies
04/17/2002EP1196554A1 Methods of cloning and producing fragment chains with readable information content
04/17/2002EP1121421A4 Materials and methods for the modification of plant lignin content
04/17/2002CN1344799A Regulation and control of cane sugar content in sugar cane
04/17/2002CN1082819C United pharmaceutical system for abrogation of viral resistance to nucleoside analogues by double-stranded RNAS
04/11/2002WO2002004597A3 Method and apparatus for synthesis of arrays of dna probes
04/11/2002US20020042930 Regulation and manipulation of sucrose content in sugarcane
04/04/2002WO2002026930A2 Nucleic acids, proteins, and antibodies
04/04/2002WO2001055178A9 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer
04/03/2002EP1192280A1 Synthetic ligation reassembly in directed evolution
04/03/2002EP1192256A1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance
03/2002
03/28/2002WO2002024909A2 Receptor nucleic acids and polypeptides
03/28/2002WO2002024225A1 Use of immidazoquinolinamines as adjuvants in dna vaccination
03/28/2002WO2001094546A3 Primer extension using a mixture of labelled and unlabelled nucleotides
03/28/2002US20020037519 Detecting protein binding positions in nucleotide sequences; obtain sequence, evaluate and compare to control binding sequences in libraries, determine binding positions
03/28/2002CA2422863A1 Use of immidazoquinolinamines as adjuvants in dna vaccination
03/27/2002CN1342200A Crystalline TNF-alpha-converting enzyme and uses thereof
03/26/2002US6362319 Glial cell line-derived neurotrophic factor
03/26/2002US6361996 Capable of self-renewal and of differentiation into neurons, astrocytes, and oligodendrocytes
03/21/2002WO2002022776A2 Human coagulation factor vii variants
03/21/2002US20020034798 High-activity phytase compositions
03/21/2002CA2420892A1 Human coagulation factor vii variants
03/14/2002US20020031530 In ovo vaccination against coccidiosis
03/07/2002WO2001085915A3 Identifying clusters of transcription factor binding sites
03/07/2002WO2001081542A3 Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data
03/07/2002WO2001066697A3 Serum free cultivation of primate embryonic stem cells
03/07/2002WO2001055178A3 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer
03/06/2002CN1339066A Alzheimer's disease secretase
1 ... 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 ... 100